Male Artificial Urinary Sphincter Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component)), By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers), By Region, & Competition, 2020-2030F

Market Overview

Global Male Artificial Urinary Sphincter Market was valued at USD 253.25 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.35% through 2030. Urinary Incontinence (UI) represents a significant health concern with substantial economic and societal implications. The increase in cases of male urinary incontinence can be attributed to the growing prevalence of urological ailments, such as prostatitis-induced incontinence, nerve and muscle damage resulting from surgical procedures, and infections, among other factors, all of which contribute to disruptions in bladder function. One potential factor is the enlargement of the prostate gland, a condition known as benign prostate hyperplasia, which tends to occur with age. Another potential trigger is prostatitis, characterized by inflammation of the prostate gland. Furthermore, incontinence can also arise as a consequence of nerve and muscle impairment caused by surgical interventions.

Key Market Drivers

Rising Aging Population

The global healthcare landscape is undergoing a transformative shift as the world witnesses an unprecedented increase in the aging population. As longevity becomes the norm, age-related medical conditions are on the rise, one of which is urinary incontinence. The world is witnessing a demographic revolution, with a substantial portion of the global population entering their golden years. In 2017, the global population aged 60 and above reached approximately 962 million, marking a 2.5-fold increase from 1980, when the figure stood at 382 million. According to long-term demographic projections, this segment is expected to double once more by 2050, surpassing 2.1 billion individuals. This significant demographic shift is creating an ever-expanding pool of potential patients in need of treatment for age-related health issues, including urinary incontinence. Data indicates that approximately 15% of older adults living independently in the community and nearly 50% of those in long-term care facilities experience severe forms of UI. Urinary incontinence, a condition characterized by the involuntary leakage of urine, is more prevalent among older adults. Aging brings about various physiological changes, such as muscle weakening and hormonal imbalances, which can contribute to urinary incontinence. Additionally, age-related medical conditions like benign prostate hyperplasia (BPH) and prostatitis are common culprits. As the aging population grows, so does the prevalence of these conditions, necessitating effective treatment options. The desire for an improved quality of life among the elderly is a significant driving force behind the growth of the male artificial urinary sphincter market. Urinary incontinence can have a profound impact on an individual's daily life, leading to social isolation, embarrassment, and a loss of independence. Recognizing the importance of preserving the dignity and well-being of older adults, healthcare providers are increasingly recommending male artificial urinary sphincters as a solution. In tandem with the aging population, advancements in medical technology have improved the design and effectiveness of male artificial urinary sphincters. Modern devices offer better control over urinary function, fewer complications, and enhanced patient comfort. These innovations have made these devices a more attractive and viable option for older individuals seeking to regain their independence and quality of life. As the aging population grows, so does healthcare spending. Governments and private healthcare providers are allocating more resources to address the unique needs of older adults. This increased investment in healthcare infrastructure and services includes the adoption of advanced medical technologies, such as male artificial urinary sphincters, which are crucial for improving the quality of care and the overall well-being of aging patients.

Prevalence of Urological Disorders

The global healthcare landscape is witnessing a surge in the prevalence of urological disorders, and this phenomenon is reshaping the landscape of medical technology. The incidence of urologic disorders among elderly patients in geriatric specialty hospitals stands at 26.5%, representing a 30% higher prevalence compared to the 19.9% observed in general hospitals. One significant beneficiary of this trend is the male artificial urinary sphincter market. Urological disorders encompass a range of conditions affecting the urinary tract and male reproductive organs. These disorders include benign prostate hyperplasia (BPH), prostatitis, and other ailments that can lead to urinary incontinence. The global prevalence of these disorders has been on the rise, primarily due to factors such as aging demographics and changes in lifestyle. As the global population ages, the incidence of urological disorders, particularly those associated with aging, has increased significantly. BPH, a non-cancerous enlargement of the prostate gland, is a prime example. Benign Prostatic Hyperplasia (BPH), commonly referred to as prostate enlargement, is the most prevalent urological condition affecting men over the age of 50. By the age of 60, approximately 50% of men are affected, with the prevalence rising sharply to 90% by age 85. These conditions often lead to urinary incontinence, which necessitates effective management and treatment options like male artificial urinary sphincters. Urological disorders, when left untreated, can have a profound impact on an individual's quality of life. Frequent urination, discomfort, and urinary incontinence can lead to social isolation, reduced mobility, and emotional distress. As awareness of these quality-of-life issues grows, patients and healthcare providers alike are seeking more advanced and reliable solutions. Male artificial urinary sphincters have emerged as a lifeline for individuals battling urological disorders that result in urinary incontinence. These devices are designed to provide precise control over urinary function, offering patients greater independence and an enhanced quality of life. The rising prevalence of urological disorders has driven increased demand for these innovative solutions. The growth of the male artificial urinary sphincter market is further propelled by continuous advancements in medical technology. Modern devices are more sophisticated, user-friendly, and associated with fewer complications. This encourages both healthcare providers and patients to consider these solutions as a viable option for managing urological disorders. Growing awareness about urological disorders and the available treatment options is another pivotal factor. Patients are now more informed about their conditions, leading to proactive healthcare-seeking behaviors. Healthcare providers, in turn, are better educated about the benefits of male artificial urinary sphincters and are more inclined to recommend them as part of a comprehensive treatment plan.

Advancements in Medical Technology

In an era characterized by relentless innovation, medical technology has become a driving force behind advancements in healthcare. One area where this is particularly evident is in the growth of the global male artificial urinary sphincter market. Advancements in medical technology have revolutionized the way we diagnose, treat, and manage various health conditions. This holds true for the field of urology and the treatment of male urinary incontinence. Modern medical technology is enabling healthcare professionals to provide more effective, minimally invasive, and patient-centric solutions. One of the key factors driving the growth of the male artificial urinary sphincter market is the increased precision and control offered by advanced technologies. These devices have evolved to provide patients with a high degree of control over urinary function. They are equipped with sensors, microprocessors, and customizable settings, allowing users to adjust the device to their specific needs. This level of precision enhances patient outcomes and comfort. Advancements in medical technology have led to male artificial urinary sphincters with improved safety profiles. Modern devices are designed to minimize complications and side effects, making them a safer and more attractive option for both patients and healthcare providers. As these safety features become more pronounced, the market is likely to experience continued growth. Technological advancements have also led to the development of minimally invasive procedures for implanting male artificial urinary sphincters. These procedures are less traumatic for patients, resulting in reduced recovery times and improved overall patient experiences. Minimally invasive approaches have broadened the appeal of these devices and expanded their potential patient base. Technological advancements have also led to the development of minimally invasive procedures for implanting male artificial urinary sphincters. These procedures are less traumatic for patients, resulting in reduced recovery times and improved overall patient experiences. Minimally invasive approaches have broadened the appeal of these devices and expanded their potential patient base. The rise of telemedicine and remote monitoring has further accelerated the adoption of male artificial urinary sphincters. Patients can now consult with healthcare providers, receive device adjustments, and monitor their progress remotely, reducing the need for frequent in-person visits. This convenience factor is making the devices more accessible to a wider range of patients. Modern male artificial urinary sphincters are often designed with a patient-centered approach. Feedback from patients and healthcare professionals informs the design and functionality of these devices, ensuring that they meet the specific needs and preferences of users. This approach not only enhances patient satisfaction but also contributes to the continued growth of the market.

Quality of Life Considerations

Quality of life is a fundamental aspect of well-being, and advancements in healthcare technologies are increasingly focused on improving the lives of individuals affected by various medical conditions. In the realm of urology, male urinary incontinence can significantly compromise one's quality of life. Urinary incontinence is a condition characterized by the involuntary loss of urine, and it can have profound effects on an individual's daily life. Beyond the physical discomfort, the emotional and psychological toll of urinary incontinence can be substantial. Individuals often experience embarrassment, social isolation, a loss of self-esteem, and limitations on their daily activities. Quality of life considerations play a central role in driving the adoption of male artificial urinary sphincters. These devices offer individuals suffering from urinary incontinence a chance to regain their dignity and independence. By providing effective control over urinary function, male artificial urinary sphincters empower users to engage in activities they may have previously avoided, thereby improving their overall quality of life. The psychological well-being of individuals with urinary incontinence is a critical factor in their overall health. Constant worry about accidents, anxiety about social interactions, and the frustration of being unable to engage in once-loved activities can take a toll on mental health. Male artificial urinary sphincters address these concerns by offering a sense of security and control, ultimately contributing to better mental well-being. The social isolation experienced by many individuals with urinary incontinence can lead to feelings of loneliness and depression. Quality of life considerations are driving the use of male artificial urinary sphincters to facilitate social reintegration. These devices enable users to participate in social activities, maintain relationships, and lead more fulfilling lives. Urinary incontinence often disrupts sleep patterns, leading to fatigue and a reduced quality of life. Male artificial urinary sphincters can significantly reduce nighttime awakenings due to urinary urgency, allowing users to enjoy uninterrupted and restful sleep. This improved sleep quality contributes to overall well-being. The restoration of continence through male artificial urinary sphincters can boost self-esteem and confidence levels. When individuals regain control over their bladder, they often experience a sense of accomplishment and empowerment, leading to a more positive self-image and improved quality of life.

Download Free Sample Report

Key Market Challenges

High Cost of Treatment

One of the primary challenges facing the male artificial urinary sphincter market is the high cost associated with the treatment. The surgical procedure to implant these devices, along with the device itself, can be expensive. This poses a significant financial burden on patients, especially those without adequate health insurance coverage or access to healthcare resources.

Limited Access to Healthcare

Access to healthcare services varies widely around the world, and not all individuals have equal access to advanced treatments like male artificial urinary sphincters. Rural areas and underserved populations may face challenges in accessing specialized urological care and the necessary surgical procedures.

Inadequate Insurance Coverage

In many regions, insurance coverage for male artificial urinary sphincters may be limited or nonexistent. Patients may be required to bear a substantial portion of the costs themselves, discouraging some from seeking treatment.

Key Market Trends

Minimally Invasive Procedures

A major trend on the horizon is the increasing adoption of minimally invasive procedures for the implantation of male artificial urinary sphincters. These techniques, often involving smaller incisions and less tissue disruption, offer patients shorter recovery times, reduced post-operative pain, and lower risk of complications. As minimally invasive procedures become more refined and accessible, they are likely to become the preferred approach for implanting these devices.

Enhanced Device Technology

Continual advancements in device technology are expected to drive innovation in the male artificial urinary sphincter market. Manufacturers are focusing on creating devices with improved precision, user-friendliness, and durability. Enhanced sensors, better control mechanisms, and connectivity options for remote monitoring are among the developments on the horizon. These technological enhancements will offer patients more personalized and effective solutions for managing urinary incontinence.

Customization and Personalization

Personalized healthcare is becoming increasingly important, and this trend is extending to the male artificial urinary sphincter market. Devices are being designed with greater flexibility to accommodate individual patient needs. Customization options for pressure settings, fluid volume, and timing of sphincter activation will enable urologists to tailor treatments to the unique requirements of each patient.

Segmental Insights

Type Insights

Based on the category of Type, AUS with a balloon reservoir (3-component) segment emerges as the fastest growing segment in the Global Male Artificial Urinary Sphincter Market. The 3-component AUS system, which includes a cuff, pump, and balloon reservoir, is widely recognized for its high success rates in restoring continence in male patients suffering from severe stress urinary incontinence, particularly post-prostatectomy. Its proven long-term durability and consistent pressure regulation through the balloon reservoir offer more precise control, minimizing leakage and improving patient quality of life.

Innovations in design and materials such as more durable cuffs and biocompatible balloon reservoirs have enhanced the performance and longevity of these devices. Additionally, ongoing R&D efforts have resulted in more anatomically adaptable systems, allowing for tailored surgical implantation based on individual patient needs. These developments have increased both surgeon confidence and patient outcomes, accelerating market adoption. The global rise in prostate surgeries, including prostatectomies due to prostate cancer or benign prostatic hyperplasia (BPH), has led to a parallel increase in cases of urinary incontinence among men. As awareness about available treatment options grows, the demand for clinically effective and permanent solutions like the 3-component AUS is surging, especially in developed and emerging markets alike.

Download Free Sample Report

Regional Insights

Based on region, Europe region was emerged as the largest market in the Global Male Artificial Urinary Sphincter Market. Europe has witnessed a significant rise in prostate cancer diagnoses and prostate surgeries, particularly prostatectomies, which often result in male stress urinary incontinence. This has created a growing patient population in need of advanced continence management solutions, such as artificial urinary sphincters. The increasing clinical demand has directly contributed to the expansion of the AUS market in the region.

European countries benefit from universal or near-universal healthcare systems, which provide wide access to urological care and cover a significant portion of costs related to AUS procedures. Reimbursement frameworks in countries like Germany, France, and the UK incentivize the adoption of technologically advanced devices, making AUS treatment more accessible to patients. Europe is home to several leading urology research institutes, surgical training centers, and academic hospitals, particularly in Western Europe. This has facilitated a high level of clinical expertise and adoption of sophisticated AUS systems. Surgeons are well-versed in AUS implantation techniques, including the use of 3-component balloon reservoir systems, contributing to widespread clinical usage.

Recent Developments

• In December 2024, Sumitomo Pharma America (SMPA) has announced that the U.S. Food and Drug Administration (FDA) has granted approval for vibegron (Gemtesa) for use in patients experiencing overactive bladder (OAB) symptoms associated with benign prostatic hyperplasia (BPH) who are already undergoing pharmacologic treatment. This regulatory milestone expands Gemtesa’s clinical utility and reinforces its role in addressing the dual symptom burden commonly observed in BPH patients, offering a differentiated therapeutic option within the urology pharmaceutical landscape.
• In October 2024, The UroActive™ artificial urinary sphincter (AUS) has demonstrated both efficacy and safety in the treatment of male stress urinary incontinence (SUI), based on six-month follow-up data. Findings from the SOPHIA clinical study offer early clinical validation, positioning UroActive™ as a compelling next-generation alternative to existing surgical interventions for male SUI. These results highlight its potential to address a significant unmet need in urologic care, with implications for improved patient outcomes and expanded therapeutic options in the urology device market.
• In June 2024, Uromems SAS has successfully secured USD47 million in a Series C funding round to accelerate the development of its UroActive® system the first smart, automated artificial urinary sphincter designed for the treatment of stress urinary incontinence (SUI). This latest capital infusion positions the company to advance through the final phase of clinical trials and prepare for commercial market entry, marking a pivotal step in bringing a transformative, sensor-driven urological solution to patients worldwide.
• In May 2024, Rigicon has unveiled significant advancements in prosthetic urology with the introduction of two next-generation solutions: the ContiReflex® artificial urinary sphincter and the Testi10™ testicular prosthesis. These innovations reflect the company’s strategic commitment to addressing unmet needs in male urological health by delivering technologically advanced, patient-centric solutions. The ContiReflex® aims to set a new standard in continence care, while the Testi10™ expands options in testicular restoration with enhanced anatomical design and biocompatibility.

Key Market Players

• Boston Scientific Corporation
• Zephyr Surgical Implants
• Affluent Medical
• UroMems
• Rigicon
• ProMinent GmbH
• Coloplast A/S
• Medtronic Plc
• Stryker

Report Scope:

In this report, the Global Male Artificial Urinary Sphincter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Male Artificial Urinary Sphincter Market, By Type:

o   AUS with a balloon reservoir (3-component)

o   AUS with a spring (2-component)

• Male Artificial Urinary Sphincter Market, By End-user:

o   Hospitals

o   Clinics & Other Healthcare Centers

o   Academic & Research Centers

• Male Artificial Urinary Sphincter Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  Germany

§  United Kingdom

§  France

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  Japan

§  India

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Male Artificial Urinary Sphincter Market.

Available Customizations:

Global Male Artificial Urinary Sphincter market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).